tbed

This week the Economic Development Administration (EDA) announced it had completed awarding $27.9 million in cooperative agreements to establish eight economic development Communities of Practice, including the Technology-Based Economic Development (TBED) Community of Practice led by SSTI to help build the capacity and disseminate effective technology-based economic development practices across the innovation industry

The press release for the latest report from the Intergovernmental Panel on Climate Change (IPCC) opens in what has become a tradition for environmental reporting: a dire statistic intended to inspire a desire for action.

On Tuesday, Feb. 1, SSTI’s new TBED Community of Practice hosted its first webinar as part of a multi-year effort to build capacity among Economic Development Administration (EDA) grantees to achieve greater impacts and strengthen the overall practice of technology-based economic development (TBED). Webinar participants learned about new funding sources and how they can support regional innovation economies.

A working paper published in the National Bureau of Economic Research asked the question, “Do large firms produce more valuable inventions, and if so, why?” An excerpt of an analysis of the paper that appeared in the November 2022 issue of the NBER Digest follows with additional consideration from SSTI Vice President Mark Skinner on its i

SSTI is pleased to announce a new project with the Economic Development Administration (EDA) to build a Community of Practice focused on EDA’s important technology-based economic development (TBED) investment priority area. This new partnership will help regions across the entire country become more resilient, more equitable, and more competitive in the global innovation-centered economy.

With the return of congressionally-directed spending — more commonly known as “earmarks” — for the FY 2022 budget, nearly 5,000 projects received more than $9.6 billion in such funding. The return of the earmarks followed a 10-year absence after the practice was banned in 2011. SSTI’s review of the spending data, which was collected by the Bipartisan Policy Center (BPC) from the congressional appropriations committees, showed that projects related to technology-based economic development (TBED) were included in the funding.

With a 20-year history, the Maryland Technology Development Corporation (TEDCO) is reporting an economic impact in 2021 four times greater than what they experienced in 2013. A new independent study found that its six core programs have provided “significant value” to the state’s start-up community, supporting over 10,000 jobs and more than $2 billion in statewide economic activity as of 2021. Meanwhile, BioCrossroads, a non-profit based in Indianapolis, has reported growth in its life sciences initiatives over the past 15 years.

Foundations, in almost all of their stripes, represent an underutilized but often willing partner to encourage regional innovation. Relationships may take time to nurture, but the resulting collaborations can be of critical importance for advancing your local TBED agenda. To spur your thinking, the six examples below from the past three weeks alone show the various ways foundations are stepping up to help support regional innovation and entrepreneurship.

The emerging innovation-intensive sector of urban farming is seeing heightened interest by venture capitalists, investments are growing faster than the crops: $2.4 billion so far this year at last count by PitchBook. That reflects a year over year (YoY) investment growth rate of 214 percent.  The number of individual deals also is rising 14 percent YoY. The sector is expected by many market analysts to capture an increasing share of the nation’s food supply for a number of reasons.

The news that a drug has been developed that appears to significantly reduce the risk of hospitalization or death from COVID-19, understandably garnered international attention. While most of the coverage centered on Merck, dig a bit deeper and one learns that Emory University researchers developed molnupiravir which Merck and Ridgeback Biotherapeutics have licensed.